238 related articles for article (PubMed ID: 22952423)
1. Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer.
Kalyana-Sundaram S; Shankar S; Deroo S; Iyer MK; Palanisamy N; Chinnaiyan AM; Kumar-Sinha C
Neoplasia; 2012 Aug; 14(8):702-8. PubMed ID: 22952423
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
Natrajan R; Wilkerson PM; Marchiò C; Piscuoglio S; Ng CK; Wai P; Lambros MB; Samartzis EP; Dedes KJ; Frankum J; Bajrami I; Kopec A; Mackay A; A'hern R; Fenwick K; Kozarewa I; Hakas J; Mitsopoulos C; Hardisson D; Lord CJ; Kumar-Sinha C; Ashworth A; Weigelt B; Sapino A; Chinnaiyan AM; Maher CA; Reis-Filho JS
J Pathol; 2014 Apr; 232(5):553-65. PubMed ID: 24395524
[TBL] [Abstract][Full Text] [Related]
3. The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.
Przybytkowski E; Ferrario C; Basik M
BMC Med Genomics; 2011 Jan; 4():16. PubMed ID: 21272361
[TBL] [Abstract][Full Text] [Related]
4. Genomic hotspots but few recurrent fusion genes in breast cancer.
Fimereli D; Fumagalli D; Brown D; Gacquer D; Rothé F; Salgado R; Larsimont D; Sotiriou C; Detours V
Genes Chromosomes Cancer; 2018 Jul; 57(7):331-338. PubMed ID: 29436103
[TBL] [Abstract][Full Text] [Related]
5. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
[TBL] [Abstract][Full Text] [Related]
6. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
7. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
8. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
[TBL] [Abstract][Full Text] [Related]
9. NRG1 fusions in breast cancer.
Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW
Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557
[TBL] [Abstract][Full Text] [Related]
10. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional consequences of genomic structural aberrations in breast cancer.
Inaki K; Hillmer AM; Ukil L; Yao F; Woo XY; Vardy LA; Zawack KF; Lee CW; Ariyaratne PN; Chan YS; Desai KV; Bergh J; Hall P; Putti TC; Ong WL; Shahab A; Cacheux-Rataboul V; Karuturi RK; Sung WK; Ruan X; Bourque G; Ruan Y; Liu ET
Genome Res; 2011 May; 21(5):676-87. PubMed ID: 21467264
[TBL] [Abstract][Full Text] [Related]
12. Identification of fusion genes in breast cancer by paired-end RNA-sequencing.
Edgren H; Murumagi A; Kangaspeska S; Nicorici D; Hongisto V; Kleivi K; Rye IH; Nyberg S; Wolf M; Borresen-Dale AL; Kallioniemi O
Genome Biol; 2011; 12(1):R6. PubMed ID: 21247443
[TBL] [Abstract][Full Text] [Related]
13. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
[TBL] [Abstract][Full Text] [Related]
14. Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer.
Heinonen H; Nieminen A; Saarela M; Kallioniemi A; Klefström J; Hautaniemi S; Monni O
BMC Genomics; 2008 Jul; 9():348. PubMed ID: 18652687
[TBL] [Abstract][Full Text] [Related]
15. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
[TBL] [Abstract][Full Text] [Related]
16. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.
Chao HH; He X; Parker JS; Zhao W; Perou CM
PLoS One; 2012; 7(12):e51719. PubMed ID: 23284754
[TBL] [Abstract][Full Text] [Related]
17. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.
Veeraraghavan J; Ma J; Hu Y; Wang XS
Breast Cancer Res Treat; 2016 Jul; 158(2):219-32. PubMed ID: 27372070
[TBL] [Abstract][Full Text] [Related]
18. RNA-Seq mapping and detection of gene fusions with a suffix array algorithm.
Sakarya O; Breu H; Radovich M; Chen Y; Wang YN; Barbacioru C; Utiramerur S; Whitley PP; Brockman JP; Vatta P; Zhang Z; Popescu L; Muller MW; Kudlingar V; Garg N; Li CY; Kong BS; Bodeau JP; Nutter RC; Gu J; Bramlett KS; Ichikawa JK; Hyland FC; Siddiqui AS
PLoS Comput Biol; 2012; 8(4):e1002464. PubMed ID: 22496636
[TBL] [Abstract][Full Text] [Related]
19. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.
Couch FJ; Wang XY; Wu GJ; Qian J; Jenkins RB; James CD
Cancer Res; 1999 Apr; 59(7):1408-11. PubMed ID: 10197603
[TBL] [Abstract][Full Text] [Related]
20. Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.
Agelopoulos K; Greve B; Schmidt H; Pospisil H; Kurtz S; Bartkowiak K; Andreas A; Wieczorek M; Korsching E; Buerger H; Brandt B
BMC Cancer; 2010 Mar; 10():78. PubMed ID: 20199686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
